Close X
Get more out of WDDTY.com
by joining the site for free
Free 17-point plan to great health
Twice weekly e-news bulletins
Access to our News, Forums and Blogs
Sign up for free and claim your
17-point plan to great health
Free 17-point plan to great health

Twice weekly e-news bulletins

Access to our News, Forums and Blogs
OR

If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.


Click here if you're interested
Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!

News2007June › Approve Our Drug Or Else: How drug companies follow the scientific method › June 2007

Approve Our Drug Or Else: How drug companies follow the scientific method

Those seven of you who still believe the pharmaceutical industry is driven more by a desire to help mankind than its shareholders might be interested in discussions between drug company executives and UK government ministers

Those seven of you who still believe the pharmaceutical industry is driven more by a desire to help mankind than its shareholders might be interested in discussions between drug company executives and UK government ministers.

The notes from the meetings have just been made public under Freedom of Information legislation - and it makes for interesting reading.

It reveals bully-boy tactics and threats from the drug company executives to get their drugs 'fast-tracked' for acceptance within the National Health Service.

At one meeting Pfizer executives suggested they could withdraw their investment in the UK unless NICE (National Institute for Clinical Excellence), the body that determines which drugs can be prescribed under the NHS, reconsidered its refusal of its Alzheimer's drug.

Government ministers were told that Pfizer has annual revenues of $52.5bn (lb28bn), and that the company might "take its business elsewhere" unless the government helped create a more "robust" environment for pharmaceuticals in the UK.

Richard Marsh, director of external affairs at Bristol-Myers Squibb, who also attended one of the government meetings, said drug companies wanted to invest in countries with a "favourable environment".

In other words, governments are being told to either just approve drugs, without all the time-consuming safety and efficacy checks, or lose substantial inward investment.

There is the small matter of the safety of the patient, we suppose, but if we're talking about the balance of payments, well. . .

(Source: The Guardian, 28 September 2006)

E-news broadcast 28 September 2006 No.296 [Subscribe]


You may also be interested in...

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2017 WDDTY Publishing Ltd.
All Rights Reserved